HIP-55 mediates angiotensin Ⅱ-induced vascular collagen deposition

Kai Liu,Zijian Li

DOI: https://doi.org/10.3969/j.issn.1007-5410.2019.02.015

2019-01-01

Abstract:Objective To investigate whether HIP-55 mediates angiotensin Ⅱ-induced vascular collagen deposition. Methods Using bioinformatics analysis method predicted whether HIP-55 was involved in angiotensin Ⅱ-induced vascular remodeling; an angiotensin Ⅱ (1 mg·kg-1·d-1 ) micropump was implanted subcutaneously in the back of the mouse for 14 days to induce a vascular remodeling model. The blood pressure changes of the mice were detected by non-invasive blood pressure meter, RT-PCR and Western blot were used to detect the expression of HIP-55 in vascular remodeling model. HIP-55 knockout mouse were constructed and all the mouse were divided into 4 groups: wild/sham operation group ( WT/Sham group), HIP-55 gene knockout/sham operation group (HIP-55-/-/Sham group), wild/buried pump group (WT/Ang Ⅱ group) and HIP-55 gene knockout/buried pump ( HIP-55-/-/Ang Ⅱ group) . Using aortic HE staining and Masson staining methods, the changes of vascular morphology and collagen deposition were detected. Results Bioinformatics suggested that HIP-55 might be involved in angiotensinⅡ-induced vascular remodeling. The expression of vascular HIP-55 was significantly increased in angiotensinⅡ-induced vascular remodeling model (1. 6 ± 0. 15 vs. 1. 0 ± 0. 04, P <0. 01 ); The knockout of HIP-55 inhibited angiotensin Ⅱ-induced vascular collagen deposition (2. 6 ± 0. 2 vs. 3. 3 ± 0. 1, P<0. 05). Conclusions HIP-55 mediates angiotensin Ⅱ-induced vascular collagen deposition.